Paper9765152
Alterations of the PPP2R1B gene in human lung and colon cancer.
Wang SS and 6 others. Science, 1998. Cited by 340 papers, by iCite.
Cite this record
ConductScience Library. Alterations of the PPP2R1B gene in human lung and colon cancer. Papers, record 9765152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9765152
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colonic Neoplasms | Major topic |
| Genes, Tumor Suppressor | Major topic |
| Lung Neoplasms | Major topic |
| Phosphoprotein Phosphatases | Major topic |
| Amino Acid Sequence | |
| Cell Cycle | |
| Cell Division | |
| Chromosome Mapping | |
| Chromosomes, Human, Pair 11 | |
| Frameshift Mutation | |
| Humans | |
| Loss of Heterozygosity | |
| Molecular Sequence Data | |
| Point Mutation | |
| Protein Phosphatase 2 | |
| Sequence Deletion | |
| Tumor Cells, Cultured |
Source PubMed
Cited by147
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 340 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42947971 | PP2A targeting: balancing anticancer potential and neurological risk. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42947971 | PubMed |
| 42170191 | Novel examples of NMD escape through alternative intronic polyadenylation. | NAR Genom Bioinform | 2026 | https://conductscience.org/library/papers/42170191 | PubMed |
| 41724425 | Endogenous inhibitors of PP2A activate oncogenic and DNA damage response kinases in glioblastoma. | Cancer Lett | 2026 | https://conductscience.org/library/papers/41724425 | PubMed |
| 41146310 | Targeting PP2A in cancer: an underrated option. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/41146310 | PubMed |
| 40845116 | AKR1B10 dictates c-Myc stability to suppress colorectal cancer metastasis via PP2A nitration. | Sci Adv | 2025 | https://conductscience.org/library/papers/40845116 | PubMed |
| 40712571 | Regulatory mechanisms of PP2A complex assembly driven by physicochemical differences in A-subunit isoforms. | Structure | 2025 | https://conductscience.org/library/papers/40712571 | PubMed |
| 40488594 | Pan-cancer analysis of ARNT2 and its oncogenic role in cervical cancer. | J Gynecol Oncol | 2025 | https://conductscience.org/library/papers/40488594 | PubMed |
| 40413669 | Leveraging multiple cell-death patterns based on machine learning to decipher the prognosis, immune, and immune therapeutic response of soft tissue sarcoma. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40413669 | PubMed |
| 40178903 | Germline mutations in PPP2R1B in patients with a personal and family history of cancer. | JCI Insight | 2025 | https://conductscience.org/library/papers/40178903 | PubMed |
| 39210544 | Single-cell multi-modal chromatin profiles revealing epigenetic regulations of cells in hepatocellular carcinoma. | Clin Transl Med | 2024 | https://conductscience.org/library/papers/39210544 | PubMed |
| 38429738 | PPP2R1B abolishes colorectal cancer liver metastasis and sensitizes Oxaliplatin by inhibiting MAPK/ERK signaling pathway. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/38429738 | PubMed |
| 38184584 | Altering phosphorylation in cancer through PP2A modifiers. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/38184584 | PubMed |
| 37763671 | Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases. | Medicina (Kaunas) | 2023 | https://conductscience.org/library/papers/37763671 | PubMed |
| 36555359 | The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36555359 | PubMed |
| 36340025 | An interactive analysis of the mouse oviductal miRNA profiles. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/36340025 | PubMed |
| 35754740 | Sensitization of FOLFOX-resistant colorectal cancer cells via the modulation of a novel pathway involving protein phosphatase 2A. | iScience | 2022 | https://conductscience.org/library/papers/35754740 | PubMed |
| 34686773 | PP2A-B55: substrates and regulators in the control of cellular functions. | Oncogene | 2022 | https://conductscience.org/library/papers/34686773 | PubMed |
| 34512348 | The Downregulation of eIF3a Contributes to Vemurafenib Resistance in Melanoma by Activating ERK via PPP2R1B. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34512348 | PubMed |
| 34445444 | Insights on Metabolic Reprogramming and Its Therapeutic Potential in Acute Leukemia. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445444 | PubMed |
| 34422684 | PP2A Phosphatase as an Emerging Viral Host Factor. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/34422684 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PPP2R1B | 5519 | Swiss-Prot's references | https://conductscience.org/library/genes/5519 | NCBI Gene |
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| PTPA | 5524 | PubTator's text mining | https://conductscience.org/library/genes/5524 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | AF087438 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9765152
GET https://conductscience.org/api/papers/v1/9765152/cited_by?page=2